SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000819050-23-000052
Filing Date
2023-05-10
Accepted
2023-05-10 16:07:49
Documents
53
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q frtx-20230331.htm   iXBRL 10-Q 805827
2 EX-10.9 a2023033110qex109.htm EX-10.9 18428
3 EX-31.1 a2023033110qex311.htm EX-31.1 10119
4 EX-31.2 a2023033110qex312.htm EX-31.2 9819
5 EX-32.1 a2023033110qex321.htm EX-32.1 9361
11 frtx-20230331_g1.jpg GRAPHIC 256028
  Complete submission text file 0000819050-23-000052.txt   4396448

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT frtx-20230331.xsd EX-101.SCH 32833
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT frtx-20230331_cal.xml EX-101.CAL 30877
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT frtx-20230331_def.xml EX-101.DEF 129130
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT frtx-20230331_lab.xml EX-101.LAB 354926
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT frtx-20230331_pre.xml EX-101.PRE 223458
47 EXTRACTED XBRL INSTANCE DOCUMENT frtx-20230331_htm.xml XML 458071
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21088 | Film No.: 23906375
SIC: 2836 Biological Products, (No Diagnostic Substances)